Home > Insider Trading > Filing (0001209191-15-086952)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1008848	Acorda Therapeutics Inc	ACOR	Biological Products, (No Disgnostic Substances) (2836)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1352455	Jane Wasman	420 Saw Mill River Road Ardsley NY 10502	President, Intl And Gc	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2015-12-22	5,342	$5.85	113,921	No	4	M	Direct
Common Stock	Disposition	2015-12-22	5,342	$43.00	108,579	No	4	S	Direct
Common Stock	Disposition	2015-12-22	8,455	$42.07	100,124	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Employee Stock Option (right to buy)	Disposition	2015-12-22	5,342	$0.00	5,342	$5.85

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
10,751		2016-03-17	No	4	M	Direct

Footnotes

Exercises and sales pursuant to a 10b5-1 Plan. The exercised options were scheduled to expire in 2016 on the expiration date reported within Table II unless exercised.
Sales pursuant to a 10b5-1 plan.
The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $42.00 to $42.30 per share. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regardingthe number of shares sold at each price within the range.
The shares subject to these options vested in installments and were fully vested on February 10, 2010.